Drugs / Investigational Trivalent Inactivated Influenza Vaccine
Investigational Trivalent Inactivated Influenza Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01218646 | Oct 2010 → Mar 2011 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Investigational Trivalent Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01218646 ↗ |
| Modality | Vaccine | “Investigational Trivalent Inactivated Influenza Vaccine” NCT01218646 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01218646 ↗ |